From March 10, 2022 to June 10, 2022, the company has repurchased 519,451 shares, representing 1.01% for KRW 10,000.02 million. With this, the company has completed the repurchase of 519,451 shares, representing 1.01% for KRW 10,000.02 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33,000 KRW | +0.15% | +0.61% | -25.51% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.51% | 1.21B | |
+52.93% | 803B | |
+40.98% | 631B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 243B | |
+2.17% | 228B | |
+10.66% | 217B | |
+6.24% | 164B |
- Stock Market
- Equities
- A009420 Stock
- News Hanall Biopharma Co., Ltd.
- Tranche Update on Hanall Biopharma Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.